Results for tag: "Proteinuria Drug"

The Proteinuria Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. Proteinuria is a condition in which the body excretes an abnormally high amount of protein in the urine. Proteinuria drugs are used to reduce the amount of protein in the urine and to treat the underlying cause of the condition. These drugs are typically prescribed to patients with chronic kidney disease, nephrotic syndrome, and other kidney and liver disorders. Commonly prescribed proteinuria drugs include ACE inhibitors, angiotensin receptor blockers, diuretics, and immunosuppressants. Some companies in the Proteinuria Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more